IP Library Granted Patent US 11,788,070
Granted Patent B2
US 11,788,070 · App. 17/495,139 · Granted Oct 17, 2023

Uridine diphosphate-dependent glycosyltransferase enzyme

Inventors: Jason Eric Donald (Watertown, MA); Ajikumar Parayil Kumaran (Lexington, MA); Aaron Love (Cambridge, MA); Christopher Toomey (Cambridge, MA); Christine Nicole S. Santos (Newton, MA)
Assignee: Manus Bio Inc.
C12N9/1051C12N15/52C12P19/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,788,070
App. No.
17/495,139
Granted
Oct 17, 2023
Kind
B2
Abstract

In various aspects, the present invention provides uridine diphosphate-dependent glycosyltransferase (UGT) enzymes capable of catalyzing the transfer of a monosaccharide moiety from a NDP-sugar to the 3′ carbon of a sugar moiety of a substrate, such as a terpenoid glycan, thereby functioning as a “1-3 UGT.” In other aspects, the invention provides polynucleotides encoding the 1-3 UGT, and host cells comprising the same. In still other aspects, the invention provides methods for preparing glycosylated substrates, including steviol glycosides, using the enzyme and host cells of this disclosure.

Claims (21)

1. A uridine diphosphate-dependent glycosyltransferase (UGT) enzyme comprising an amino acid sequence that is at least 95% identical to the amino acid sequence of SEQ ID NO: 9.

2. The enzyme of claim 1 , comprising one or more of:

a glycine (G) at the position corresponding to position 54 of SEQ ID NO: 5;

a leucine (L) at the position corresponding to position 111 of SEQ ID NO: 5; and

a methionine (M) at the position corresponding to position 183 of SEQ ID NO: 5.

3. The enzyme of claim 2 , wherein the enzyme has Gly at the position corresponding to position 54 of SEQ ID NO: 5, Leu at the position corresponding to position 111 of the SEQ ID NO: 5, and a Met at the position corresponding to position 183 of SEQ ID NO: 5.

4. The enzyme of claim 1 , wherein the enzyme comprises an insertion with respect to SEQ ID NO: 5 of from about 6 to about 12 amino acids after the position corresponding to position 155 of SEQ ID NO: 5.

5. The enzyme of claim 4 , wherein the insertion is a flexible and hydrophilic sequence that is predominately Glycine and Serine residues.

6. The enzyme of claim 1 , wherein the enzyme comprises a deletion with respect to SEQ ID NO: 6 of one or more amino acids corresponding to amino acids E225 to T232 of SEQ ID NO: 6.

7. The enzyme of claim 6 , wherein the enzyme comprises a deletion with respect to SEQ ID NO: 6 of the amino acids corresponding to amino acids E225 to T232 of SEQ ID NO: 6.

8. The enzyme of claim 1 , wherein the enzyme comprises an amino acid substitution with respect to SEQ ID NO: 6 at one or more positions corresponding to position 72, position 305, position 345, and position 428 of SEQ ID NO: 6.

9. The enzyme of claim 8 , wherein the enzyme comprises one or more amino acid substitutions with respect to SEQ ID NO: 6 selected from: a glutamine (Q) at the position corresponding to position 72 of SEQ ID NO: 6; a cysteine (C) at the position corresponding to position 305 of SEQ ID NO: 6; a phenylalanine (F) at the position corresponding to position 345 of SEQ ID NO: 6; and an isoleucine (I) at the position corresponding to position 428 of SEQ ID NO: 6.

10. A polynucleotide encoding the enzyme of claim 1 .

11. An isolated recombinant microorganism comprising the polynucleotide of claim 10 .

12. The enzyme of claim 1 , wherein the enzyme comprises one or more of the following substitutions with respect to SEQ ID NO: 6: S72Q, A305C, Y345F, and L428I.

13. The enzyme of claim 1 , wherein the enzyme comprises the following substitutions with respect to SEQ ID NO: 6: S72Q, A305C, Y345F, and L428I.

14. The enzyme of claim 1 , wherein the enzyme comprises an amino acid sequence that is at least 98% identical to the amino acid sequence of SEQ ID NO: 9.

15. The enzyme of claim 1 , wherein the enzyme comprises the amino acid sequence of SEQ ID NO: 9.

16. The enzyme of claim 1 , wherein the enzyme has from 1 to 10 amino acid modifications independently selected from substitutions, deletions, and insertions, with respect to the amino acid sequence of SEQ ID NO: 9.

17. The enzyme of claim 1 , wherein the enzyme has from 1 to 5 amino acid modifications independently selected from substitutions, deletions, and insertions, with respect to the amino acid sequence of SEQ ID NO: 9.

18. The enzyme of claim 5 , wherein the insertion is GSGGSG (SEQ ID NO: 7) or GSGGSGGSG (SEQ ID NO: 8).

Assignments (4)
SECURITY INTEREST Recorded Sep 8, 2025
From: MANUS BIO INC.; STO.PERU I LLC; STO.PERU II LLC; MANUS INTERMEDIATE INC.; MANUS INSCRIPTA, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 072836/0255 →
RELEASE OF SECURITY INTEREST Recorded May 9, 2025
From: EICF AGENT LLC
To: MANUS BIO INC.
Reel/Frame 071247/0658 →
SECURITY AGREEMENT Recorded Apr 1, 2022
From: MANUS BIO INC.
To: EICF AGENT LLC
Reel/Frame 059568/0683 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2021
From: KUMARAN, AJIKUMAR PARAYIL; DONALD, JASON ERIC; LOVE, AARON; TOOMEY, CHRISTOPHER; SANTOS, CHRISTINE NICOLE S.
To: MANUS BIO INC.
Reel/Frame 057740/0127 →
Continuity (3)
Continuation 16912374 · Jun 25, 2020
Provisional Application 62866148 · Jun 25, 2019
Related Publication 20220090031A1 · Mar 24, 2022